These TAMs, in turn, produce elevated levels of CCL18, which induces EMT in breast cancer cells via the phosphatidylinositol 3-kinase (PI3K)/Akt/glycogen synthase kinase 3β (GSK3β)/SNAIL signaling pathway. This evidence concerns the gene SNAI1 and breast cancer.